Literature DB >> 31482496

Application of Fluorescence in Studying Therapeutic Enzymes.

Zhaoshuai Wang1, Caihong Li2, Yinan Wei3.   

Abstract

Fluorescence spectroscopy is one of the most important techniques in the study of therapeutic enzymes. The fluorescence phenomenon has been discovered and exploited for centuries, while therapeutic enzymes have been used in treatment of disease for only decades. This chapter provides a brief summary of the current applications of fluorescence methods in studying therapeutic enzymes to provide some insights on the selection of proper method tailored to the goal. First a brief introduction about therapeutic enzymes and history of fluorescence were provided, followed by discussions on how fluorescence was applied in the studies. Four popular fluorescence methods are discussed: fluorescence tracing, fluorescence resonance energy transfer (FRET), fluorescence quenching and fluorescence polarization. Selected application of the fluorescence methods in studying therapeutic enzymes are listed, and discussed in details in the following paragraphs.

Entities:  

Keywords:  FRET; Fluorescence polarization; Fluorescence quenching; Fluorescence tracing; Therapeutic enzyme

Mesh:

Substances:

Year:  2019        PMID: 31482496     DOI: 10.1007/978-981-13-7709-9_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  44 in total

1.  Interaction of a novel fluorescent analog of interferon-gamma with transformed cells.

Authors:  A Falach; I Nathan; S Baram; N Porat; A Dvilansky; A H Parola
Journal:  Bioconjug Chem       Date:  1997 Jul-Aug       Impact factor: 4.774

2.  A carbon nanotubes based fluorescent aptasensor for highly sensitive detection of adenosine deaminase activity and inhibitor screening in natural extracts.

Authors:  Kun Hu; Yong Huang; Sheng'e Wang; Shulin Zhao
Journal:  J Pharm Biomed Anal       Date:  2014-03-12       Impact factor: 3.935

Review 3.  Enzymes as agents for the treatment of disease.

Authors:  D M Goldberg
Journal:  Clin Chim Acta       Date:  1992-03-13       Impact factor: 3.786

4.  The N-terminal region of Escherichia coli lactose permease mediates membrane contact of the nascent polypeptide chain.

Authors:  U Stochaj; R Ehring
Journal:  Eur J Biochem       Date:  1987-03-16

Review 5.  Next generation antibody drugs: pursuit of the 'high-hanging fruit'.

Authors:  Paul J Carter; Greg A Lazar
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

6.  Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

Authors:  Lapo Alinari; Bo Yu; Beth A Christian; Fengting Yan; Jungook Shin; Rosa Lapalombella; Erin Hertlein; Mark E Lustberg; Carl Quinion; Xiaoli Zhang; Gerard Lozanski; Natarajan Muthusamy; Mette Prætorius-Ibba; Owen A O'Connor; David M Goldenberg; John C Byrd; Kristie A Blum; Robert A Baiocchi
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

Review 7.  Therapeutic antibodies for autoimmunity and inflammation.

Authors:  Andrew C Chan; Paul J Carter
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

8.  The First Pentacyclic Triterpenoid Gypsogenin Derivative Exhibiting Anti-ABL1 Kinase and Anti-chronic Myelogenous Leukemia Activities.

Authors:  Halil Ibrahim Ciftci; Safiye Emirdag Ozturk; Taha F S Ali; Mohamed O Radwan; Hiroshi Tateishi; Ryoko Koga; Zeynep Ocak; Mustafa Can; Masami Otsuka; Mikako Fujita
Journal:  Biol Pharm Bull       Date:  2018-01-30       Impact factor: 2.233

9.  Fast, three-dimensional super-resolution imaging of live cells.

Authors:  Sara A Jones; Sang-Hee Shim; Jiang He; Xiaowei Zhuang
Journal:  Nat Methods       Date:  2011-05-08       Impact factor: 28.547

10.  Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes.

Authors:  Wouter W Kallemeijn; Saskia Scheij; Sascha Hoogendoorn; Martin D Witte; Daniela Herrera Moro Chao; Cindy P A A van Roomen; Roelof Ottenhoff; Herman S Overkleeft; Rolf G Boot; Johannes M F G Aerts
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.